Clinical Trials Browser

Carcinoma, Ovarian Epithelial, Adenocarcinoma, Bile Duct Neoplasms, Biliary Tract Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Small Cell, Carcinoma, Ductal, Small Cell Lung Carcinoma, Inflammatory Breast Neoplasms

NCT04544748 2024-03-06

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

Phase 1 Unknown

48 enrolled

DermatologicGenitourinaryThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT04401059 2023-12-27

SELECT-2

Phase 4 Unknown

744 enrolled

Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT06090214 2023-10-19

BLADE

Phase NA Unknown

42 enrolled

Adenocarcinoma, Neoplastic Cells, Circulating

Clinical Trials

CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

SELECT-2

BLADE

The Safety and Efficacy of Q-1802 Combined With XELOX in Gastrointestinal Tumors

RiME

DIPLOMA

PANTELO

INTEGRATEIIa

Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

IMMUNOGAST

AVATAR

PROSPECT

Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer

TOPARP

Second-line Study of PEGPH20 and Pembro for HA High Metastatic PDAC

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC

A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

ICWIP

Icotinib Combined With Dihydroaremisinin (DHA) Therapy in Patients With Advanced NSCLC

PanHIPEC

PREPARE

PACMI

Metformin Plus Irinotecan for Refractory Colorectal Cancer

Icotinib as First-line and Maintenance Treatment in EGFR Mutated Patients With Lung Adenocarcinoma

Chemotherapy Plus Gefitinib for Advanced Lung Adenocarcinoma and Sensitive EGFR Mutations: a Randomized Controlled Trial

IRON

Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Sequential and Maintenance Icotinib Plus Chemotherapy Versus Icotinib Maintenance After Chemotherapy in Advanced NSCLC

AXP107-11 in Combination With Standard Gemcitabine (Gemzar® ) Therapy for Treatment in Patients With Pancreatic Cancer

Effect of Zinc on Barrett's Metaplasia

Macrophages Effect on Chemoresistance

Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma

BRASTEGAC

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers

Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma

mXELOX

mSOX

Colorectal Cancer Detection by Means of Optical Fluoroscopy

The Character of Perfusion Parameters Derived From MDCT Between Adenocarcinoma and Squamous Cell Carcinoma of Lung in the Treatment Course of Radiation Therapy

Randomized Trial on Robotic Assisted Resection for Rectal Cancer

Erlotinib and Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Failure of One Chemotherapy Regimen

GAST-TaxXel

Prospective Phase II Randomized Trial of Postoperative Adjuvant Chemotherapy in Patients With High Risk Colon Cancer